Envestnet Portfolio Solutions Inc. Acquires New Position in Envista Holdings Corporation $NVST

Envestnet Portfolio Solutions Inc. acquired a new stake in Envista Holdings Corporation (NYSE:NVST) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 54,036 shares of the company’s stock, valued at approximately $1,173,000.

A number of other hedge funds have also recently added to or reduced their stakes in NVST. Caitong International Asset Management Co. Ltd lifted its position in Envista by 16,711.1% in the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after purchasing an additional 1,504 shares during the period. Allworth Financial LP lifted its position in Envista by 75.4% in the fourth quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after purchasing an additional 776 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Envista by 73.1% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after purchasing an additional 949 shares during the period. EverSource Wealth Advisors LLC lifted its position in Envista by 378.0% in the second quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock valued at $47,000 after purchasing an additional 1,909 shares during the period. Finally, Annis Gardner Whiting Capital Advisors LLC acquired a new stake in Envista in the third quarter valued at about $54,000.

Envista Trading Down 0.1%

Shares of Envista stock opened at $23.41 on Monday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.44 and a quick ratio of 2.06. Envista Holdings Corporation has a 1 year low of $16.51 and a 1 year high of $30.42. The company has a market capitalization of $3.81 billion, a P/E ratio of 57.09, a P/E/G ratio of 1.47 and a beta of 0.92. The business has a 50 day moving average price of $25.57 and a 200 day moving average price of $24.33.

Envista (NYSE:NVST) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.05. Envista had a return on equity of 7.11% and a net margin of 2.41%.During the same quarter in the prior year, the company posted $0.24 earnings per share. Envista’s revenue was up 14.4% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Sell-side analysts anticipate that Envista Holdings Corporation will post 1.43 EPS for the current fiscal year.

Analyst Ratings Changes

NVST has been the topic of a number of research reports. Zacks Research cut Envista from a “strong-buy” rating to a “hold” rating in a report on Monday, April 6th. Citigroup started coverage on Envista in a research note on Wednesday, April 15th. They issued a “neutral” rating and a $29.00 price objective for the company. William Blair raised Envista from a “hold” rating to an “outperform” rating in a research note on Friday, February 6th. Weiss Ratings downgraded Envista from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. Finally, JPMorgan Chase & Co. raised their price objective on Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Six analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $28.83.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.